Literature DB >> 18839209

Gastroenteropancreatic neuroendocrine tumors: indications for and pitfalls of frozen section examination.

Anne Couvelard1, Alain Sauvanet.   

Abstract

Gastroenteropancreatic neuroendocrine tumors constitute a heterogeneous group of neoplasms. Surgical resection remains the only curative treatment. Frozen section examination is requested by the surgeon in a large variety of surgical situations, but its use differs greatly according to the location of the tumor and the type of surgery performed. The objective of this review is to describe the main indications for and pitfalls of frozen section examination of gastroenteropancreatic neuroendocrine tumors.

Entities:  

Mesh：

Year:  2008        PMID： 18839209     DOI： 10.1007/s00428-008-0678-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN： 0945-6317            Impact factor:   4.064


  42 in total

Review 1.  Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

Authors:  U Plöckinger; G Rindi; R Arnold; B Eriksson; E P Krenning; W W de Herder; A Goede; M Caplin; K Oberg; J C Reubi; O Nilsson; G Delle Fave; P Ruszniewski; H Ahlman; B Wiedenmann
Journal:  Neuroendocrinology       Date:  2005-04-18       Impact factor: 4.914

2.  A clear cell malignant gastrinoma of the pancreas with cytoplasmic accumulation of lipid droplets.

Authors:  Adjé Abbey-Toby; Marie-Pierre Vullierme; Alain Sauvanet; Philippe Ruszniewski; Pierre Bedossa; Anne Couvelard
Journal:  Virchows Arch       Date:  2005-09-28       Impact factor: 4.064

3.  Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated tumour/carcinoma of the appendix and goblet cell carcinoma.

Authors:  Ursula Plöckinger; Anne Couvelard; Massimo Falconi; Anders Sundin; Ramon Salazar; Emanuel Christ; Wouter W de Herder; David Gross; Wolfram H Knapp; Ulrich P Knigge; Matthew H Kulke; Ulrich F Pape
Journal:  Neuroendocrinology       Date:  2007-10-11       Impact factor: 4.914

4.  Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence, and characterization of beta-cell changes.

Authors:  Martin Anlauf; Daniel Wieben; Aurel Perren; Bence Sipos; Paul Komminoth; Andreas Raffel; Marie L Kruse; Christian Fottner; Wolfram T Knoefel; Heiner Mönig; Philipp U Heitz; Günter Klöppel
Journal:  Am J Surg Pathol       Date:  2005-04       Impact factor: 6.394

5.  Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas.

Authors:  Martin Anlauf; Aurel Perren; Cora Lu Meyer; Sonja Schmid; Parvin Saremaslani; Marie L Kruse; Eberhard Weihe; Paul Komminoth; Philipp U Heitz; Günter Klöppel
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

6.  Diffuse nesidioblastosis as a cause of hyperinsulinemic hypoglycemia in adults: a diagnostic and therapeutic challenge.

Authors:  Andreas Raffel; Markus Krausch M; Martin Anlauf; Daniel Wieben; Stefan Braunstein; Günter Klöppel; Hans-Dietrich Röher; Wolfram Trudo Knoefel
Journal:  Surgery       Date:  2007-02       Impact factor: 3.982

7.  Surgical strategy in the treatment of pancreatic neuroendocrine tumors.

Authors:  Massimo Falconi; Rossella Bettini; Letizia Boninsegna; Stefano Crippa; Giovanni Butturini; Paolo Pederzoli
Journal:  JOP       Date:  2006-01-11

8.  Pancreatic endocrine tumour with ductules: further observations of an unusual histological subtype.

Authors:  Runjan Chetty; Stefano Serra; Sylvia L Asa; N Volkan Adsay
Journal:  Pathology       Date:  2006-02       Impact factor: 5.306

Review 9.  Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.

Authors:  Günter Klöppel; Guido Rindi; Martin Anlauf; Aurel Perren; Paul Komminoth
Journal:  Virchows Arch       Date:  2007-08-08       Impact factor: 4.064

10.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064
View more
  3 in total

1.  Parenchyma-sparing resections for pancreatic neuroendocrine tumors.

Authors:  Rim Cherif; Sébastien Gaujoux; Anne Couvelard; Safi Dokmak; Marie-Pierre Vuillerme; Philippe Ruszniewski; Jacques Belghiti; Alain Sauvanet
Journal:  J Gastrointest Surg       Date:  2012-08-22       Impact factor: 3.452

Review 2.  Resistance to targeted therapies in pancreatic neuroendocrine tumors (PNETs): molecular basis, preclinical data, and counteracting strategies.

Authors:  Annemilaï Tijeras-Raballand; Cindy Neuzillet; Anne Couvelard; Maria Serova; Armand de Gramont; Pascal Hammel; Eric Raymond; Sandrine Faivre
Journal:  Target Oncol       Date:  2012-08-25       Impact factor: 4.493

3.  Incidental intraoperative discovery of a pancreatic neuroendocrine tumor associated with chronic pancreatitis.

Authors:  Valeriu Surlin; Sandu Ramboiu; Mirela Ghilusi; Iancu Emil Plesea
Journal:  Diagn Pathol       Date:  2012-09-29       Impact factor: 2.644
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.